Psoriatic Arthritis( PsA) is initially treated using a group drugs called Disease Modifying Anti Rheumatic Drugs. This does not work for everyone. The study looks at combining a DMARD called Methotrexate with Golimumab. This is a Biologics drug prescribed only after the use of a number of DMARDs has failed. Typically this means they can only be used after a number of years of disease symptoms. We hope to discover whether or not earlier use of Golimumab in conjunction with Methotrexate will produce a better outcome for patients. MRI scans will be used to help in determining this.
To find out more about taking part, read here GOLMePsA Study Information.docx (114 downloads)
Psoriatic arthritis occurs in about 1 in 6 people with psoriasis but it is difficult to diagnose. Usually in patients with psoriatic arthritis, skin psoriasis occurs prior to any joint symptoms and people are unaware of the association between the two. This study uses previously developed questionnaires to identify the condition.
This is an observational study of patients who have just received a diagnosis of PsA and aims to investigate issues which determine remission and progression of Psoriatic Arthritis.
The BSRBR-AS study is an observational study which aims to monitor the safety of treatments for Ankylosing Spondylitis (AS) patients and to find out more about how treatments affect the lives of AS patients.
Investigating polymorphism of immune response genes in psoriatic arthritis and ankylosing spondylitis.